Mirae Asset Global Investments
IMVT icon

Mirae Asset Global Investments’s Immunovant IMVT Stock Holding History

Mirae Asset Global Investments’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Sell
9,182
-1,434
-14% -$43.7K ﹤0.01% 1035
2026
Q1 		$264K Buy
10,616
+2,099
+25% +$54.3K ﹤0.01% 1033
2025
Q4 		$217K Buy
8,517
+1,778
+26% +$39.6K ﹤0.01% 1134
2025
Q3 		$109K Buy
6,739
+136
+2% +$2.2K ﹤0.01% 1197
2025
Q2 		$106K Buy
6,603
+675
+11% +$10.2K ﹤0.01% 1129
2025
Q1 		$109K Buy
5,928
+1,037
+21% +$21.7K ﹤0.01% 1116
2024
Q4 		$120K Sell
4,891
-403
-8% -$11.4K ﹤0.01% 1121
2024
Q3 		$148K Buy
5,294
+934
+21% +$27.5K ﹤0.01% 1136
2024
Q2 		$113K Sell
4,360
-67,428
-94% -$1.92M ﹤0.01% 1127
2024
Q1 		$1.33M Buy
71,788
+35,589
+98% +$1.3M ﹤0.01% 1386
2023
Q4 		$1.53M Sell
36,199
-1,202
-3% -$44.2K ﹤0.01% 1392
2023
Q3 		$1.44M Buy
37,401
+1,059
+3% +$23.9K ﹤0.01% 1343
2023
Q2 		$686K Sell
36,342
-38,030
-51% -$709K ﹤0.01% 1798
2023
Q1 		$1.15M Buy
74,372
+51,593
+226% +$895K ﹤0.01% 1466
2022
Q4 		$404K Buy
22,779
+3,207
+16% +$40.4K ﹤0.01% 1998
2022
Q3 		$109K Buy
19,572
+5,040
+35% +$24.6K ﹤0.01% 2482
2022
Q2 		$57K Buy
+14,532
New +$62.8K ﹤0.01% 2376

Other funds holding IMVT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mirae Asset Global Investments's IMVT Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Immunovant (IMVT) stake by 14% in Q2 2026, selling an estimated $43.7K and leaving 9,182 shares worth $354K. The position accounts for ﹤0.01% of the portfolio, ranked #1035.

Mirae Asset Global Investments first reported a position in IMVT in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.53M in Q4 2023. 78 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • Mirae Asset Global Investments held 9,182 shares of Immunovant worth $354K as of Q2 2026.
  • Mirae Asset Global Investments sold 1,434 Immunovant shares in Q2 2026, an estimated $43.7K.
  • Immunovant made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1035 holding.
  • Mirae Asset Global Investments first reported a position in Immunovant in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Immunovant position peaked at $1.53M in Q4 2023.
  • 78 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.